Liontrust European Growth Fund

February 2018 review

The Fund returned -1.9%* in sterling terms in February, compared with the -2.7% return from the MSCI Europe ex-UK index.

 

The market weakness at the beginning of the month was a continuation of the events seen at the tail end of January. Sovereign bonds were sold as investors considered an improving outlook for the world economy and the likelihood of tighter monetary conditions. This was intensified by better-than-expected US labour market data in February which showed wages growing ahead of consensus estimates, fuelling higher inflation expectations.

 

In the UK, the Bank of England guided to a faster pace of interest rate increases as inflation creeps higher. The market now attributes c.70% probability to another 25 basis point rise in May (following the November 2017 rate increase which was the Bank’s first in over a decade). This is up from around 44% at the beginning of the month.

 

Negative sentiment fed into equity markets, which saw sharp declines as investors repriced their inflation and interest rate expectations. Almost all sectors in the MSCI Europe ex-UK Index ended lower. In sterling terms, the worst performing sectors were real estate (-5.3%), health care (-4.5%) and consumer staples (-4.7%), while IT (+0.8%) and energy (+0.1%) were the only sectors to end in positive territory.

 

While the Fund also experienced a negative performance, it avoided the worst of the sell-off and came in ahead of the MSCI Europe ex-UK Index. This was helped by a number of companies reporting strong fourth quarter trading updates.

 

Nordic construction group Peab (+10.8%) reported a net sales increase of 7.2% to SEK14.6bn, with growth from every business area, helping to beat the consensus estimate of SEK14.2bn. Fourth quarter pre-tax profit also beat the market forecast coming in at SEK814m versus SEK781m. Oriflame (+9.6%) was another company to produce impressive fourth quarter results. The Swedish cosmetic company’s earnings before interest, taxes, depreciation and amortisation of €63.5m came in ahead of consensus at €54.6m. 

 

Paper and pulp company Stora Enso (+6.7%) recorded a 3% year-on-year rise in sales and a 47% increase in operation earnings before interest and taxes, helped by particularly strong performances in its Biomaterials and Packaging Solutions divisions. It added that sales in the first quarter of 2018 are expected to be slightly higher than that achieved in the fourth quarter of 2017. Moncler (+9.4%), meanwhile, saw a 17% increase in revenue for 2017 at constant currencies, while its net cash position nearly doubled to €305m. The Italian apparel manufacturer attributed the improvement in cash flow to better inventory management which helped offset the additional costs related to store openings.

 

The biggest detractor this month was Hexpol (-11.8%). The polymers group delivered a 6% annual increase in fourth quarter sales but analysts were concerned about operating margins, which declined to 16.0% from 17.6%. There were also worries about its ability to continue paying special dividends and pursue merger and acquisition opportunities. 

 

Swedish mining company Boliden was added to the portfolio. The company has operations in Sweden, Finland, Norway and Ireland and produces both base and precious metals.

 

Positive contributors to performance included:

Peab (+10.8%), Oriflame Holding (+9.6%) and Moncler (+9.4%).

 

Negative contributors to performance included:

Hexpol (-11.8%), Straumann Holding (-8.4%) and ING Groep (-7.5%).

 

Discrete years' performance* (%), to previous quarter-end:

 

 

Dec-17

Dec-16

Dec-15

Dec-14

Dec-13

Liontrust European Growth I Inc

11.8

26.2

8.8

4.6

16.4

MSCI Europe ex UK

15.8

18.6

5.1

-0.7

25.3

IA Europe Excluding UK

17.3

16.4

9.3

-0.9

26.1

Quartile

4

1

3

1

4

 

*Source: Financial Express, as at 28.02.2018, total return (net of fees and income reinvested), bid-to-bid, institutional class.

 

For a comprehensive list of common financial words and terms, see our glossary here.

Key Risks

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise and is not guaranteed, therefore, you may not get back the amount originally invested and potentially risk total loss of capital. The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.

Investment in Funds managed by the Cashflow Solution team involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. The Liontrust European Growth Fund holds a concentrated portfolio of stocks, if the price of one of these stocks should move significantly, this may have a notable effect on the value of the respective portfolio. The Liontrust Global Income Fund's expenses are charged to capital. The Fund’s expenses are charged to capital. This has the effect of increasing dividends while constraining capital appreciation.

Disclaimer

This content should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy.  It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, faxed, reproduced, divulged or distributed, in whole or in part, without the express written consent of Liontrust. Always research your own investments and (if you are not a professional or a financial adviser) consult suitability with a regulated financial adviser before investing.

Thursday, March 15, 2018, 4:10 PM